Procter & Gamble Company (The) (NYSE:PG – Get Free Report)’s stock price was up 1.2% during trading on Thursday . The company traded as high as $146.94 and last traded at $146.6870. Approximately 6,779,216 shares changed hands during trading, a decline of 40% from the average daily volume of 11,376,662 shares. The stock had previously closed at $144.90.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G announced a multi?year, multi?brand partnership with the WNBA to boost brand relevance, athlete collaborations and digital storytelling — a move aimed at driving engagement with younger and growing audiences that can support long?term top?line growth. P&G WNBA Partnership Aims To Build Brand Relevance And Investor Interest
- Positive Sentiment: CNBC and other outlets highlighted P&G’s “lifeblood” innovation strategy as central to a turnaround — commentary that supports confidence in margin and growth initiatives over the medium term. The strategy P&G calls its ‘lifeblood’ and why it’s key to the stock’s turnaround
- Neutral Sentiment: P&G named a new health care CEO as a 33?year veteran retires — a routine leadership succession in a strategic business unit; likely neutral for the broader stock absent guidance or structural change. P&G names new health care CEO as 33-year veteran retires
- Neutral Sentiment: Market write?ups and analysis pieces explain recent swings and investor interest in PG as a widely watched consumer staple; these summaries help context but are unlikely to move the stock materially on their own. Why Procter & Gamble (PG) Outpaced the Stock Market Today
- Negative Sentiment: Several major brokers trimmed price targets over the past 48 hours — UBS cut its PT to $166 (keeps buy), RBC lowered to $167 (keeps outperform), Goldman Sachs lowered to $155 (neutral) and Piper Sandler cut to $142 (neutral). Those downgrades reduce near?term upside expectations and increase sell?side sensitivity to execution, pressuring the stock despite maintained ratings. RBC cuts PT to $167 UBS Lowers PT to $166
- Negative Sentiment: Wells Fargo also trimmed its target to $158 while keeping an overweight rating — another signal that analysts expect slower upside from current levels even if they remain constructive on the franchise. Wells Fargo trims PT to $158
Analyst Ratings Changes
A number of equities research analysts recently commented on PG shares. Dbs Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a report on Friday, March 27th. Wells Fargo & Company dropped their price objective on shares of Procter & Gamble from $177.00 to $158.00 and set an “overweight” rating on the stock in a report on Wednesday. The Goldman Sachs Group dropped their price objective on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a report on Wednesday. Finally, Jefferies Financial Group upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and raised their price objective for the stock from $156.00 to $179.00 in a report on Tuesday, December 16th. Twelve investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $164.26.
Procter & Gamble Trading Up 1.2%
The firm has a market cap of $340.90 billion, a P/E ratio of 21.73, a P/E/G ratio of 5.04 and a beta of 0.41. The business’s 50-day moving average is $153.23 and its two-hundred day moving average is $149.32. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The business had revenue of $22.21 billion during the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.88 earnings per share. As a group, analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were given a $1.0568 dividend. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is 62.67%.
Insiders Place Their Bets
In related news, insider Balaji Purushothaman sold 12,827 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total value of $2,056,296.37. Following the completion of the transaction, the insider owned 12,639 shares of the company’s stock, valued at approximately $2,026,158.09. This trade represents a 50.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Jon R. Moeller sold 162,232 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the transaction, the chairman directly owned 319,385 shares of the company’s stock, valued at approximately $51,884,093.25. This trade represents a 33.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 348,618 shares of company stock valued at $55,462,643 in the last quarter. Company insiders own 0.20% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the company. Halbert Hargrove Global Advisors LLC bought a new position in shares of Procter & Gamble in the 3rd quarter valued at about $25,000. E Fund Management Hong Kong Co. Ltd. grew its position in shares of Procter & Gamble by 1,000.0% in the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock valued at $25,000 after acquiring an additional 150 shares during the period. Litman Gregory Wealth Management LLC bought a new position in shares of Procter & Gamble in the 4th quarter valued at about $26,000. Park Square Financial Group LLC grew its position in shares of Procter & Gamble by 65.1% in the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock valued at $26,000 after acquiring an additional 71 shares during the period. Finally, Evolution Wealth Management Inc. grew its position in shares of Procter & Gamble by 1,315.4% in the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after acquiring an additional 171 shares during the period. Institutional investors own 65.77% of the company’s stock.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
